Blog
RSS FeedPosted by Michael Wonder on 02 May 2016
Umeclidinium for symptom relief in COPD: additional benefit is not proven
2 May 2016 - No sighificant differences for moderate disease and no data for severe disease. ...
Posted by Michael Wonder on 16 Jan 2016
Aclidinium bromide in COPD: evidence of significant additional value in certain patients
15 January 2016 - With reference to new scientific evidence, the manufacturer requested a reassessment and submitted a new dossier. ...
Posted by Michael Wonder on 19 Nov 2015
Tiotropium/olodaterol in COPD: IQWiG finds disadvantages in patients with more severe disease, advantages for some women
16 November 2015 - According to the findings, there were no statistically significant differences between the treatment groups for the totality ...